David Garcia is a Hematology physician. ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
825 Eastlake Ave E
Seattle, WA 981094405
Telephone
206-288-1000Registry record last updated 6 Aug 2013.
Clinical trials
- Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)
Sponsor: Hospital Clínico Universitario de Valladolid
- InfluenCEF Study: Study on the Headache Associated With Influenza Infection
Sponsor: Hospital Clínico Universitario de Valladolid
- NUMITOR Study: Nummular Headache Iberian Study on the Treatments and Outcomes in Real-World Setting
Sponsor: Hospital Clínico Universitario de Valladolid
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20221 payment
- Abbott LaboratoriesProgram year20212 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Blood & clotting
100%Factor Xa inhibitor43.6%Eliquis100%Part D<11 patientsLow Molecular Weight Heparin28.2%Enoxaparin Sodium100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2020–2022 per NIH RePORTER. The latest:
- Health Education through Arts-based Learning (HEAL): A Partnership to Investigate Interdisciplinary Science Programs in Rural Communities
Washington State University
FY2022$231,671R25GM129814 - Health Education through Arts-based Learning (HEAL): A Partnership to Investigate Interdisciplinary Science Programs in Rural Communities
Washington State University
FY2021$254,235R25GM129814 - Health Education through Arts-based Learning (HEAL): A Partnership to Investigate Interdisciplinary Science Programs in Rural Communities
Washington State University
FY2020$257,154R25GM129814
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Tait Shanafelt, MD
Palo Alto University
Robert Bast, MD
The University of Texas MD Anderson Cancer Center
Thomas Witzig, MD
Mayo Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”